albuterol has been researched along with Breast Neoplasms in 6 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Globally breast cancer accounts for 24." | 5.91 | The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models. ( Bruque, CD; Bruzzone, A; Jabloñski, M; Lüthy, IA; Pérez Piñero, C; Rivero, EM; Rodríguez, MS; Vanzulli, S, 2023) |
| "Globally breast cancer accounts for 24." | 1.91 | The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models. ( Bruque, CD; Bruzzone, A; Jabloñski, M; Lüthy, IA; Pérez Piñero, C; Rivero, EM; Rodríguez, MS; Vanzulli, S, 2023) |
| "However, β -adrenergic action in breast cancer is controversial." | 1.46 | The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line. ( Bruzzone, A; Entschladen, F; Gargiulo, L; Lüthy, IA; Piñero, CP; Rivero, EM; Zänker, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jabloñski, M | 1 |
| Rodríguez, MS | 1 |
| Rivero, EM | 2 |
| Bruque, CD | 1 |
| Vanzulli, S | 1 |
| Bruzzone, A | 3 |
| Pérez Piñero, C | 2 |
| Lüthy, IA | 3 |
| Piñero, CP | 1 |
| Gargiulo, L | 1 |
| Entschladen, F | 1 |
| Zänker, K | 1 |
| Dilaghi, B | 1 |
| Modesti, PA | 1 |
| Conti, AA | 1 |
| Nozzoli, C | 1 |
| Sarappa, MG | 1 |
| Castillo, LF | 1 |
| Fraser, J | 1 |
| von Bueren, AO | 1 |
| Ma, R | 1 |
| Schlumpf, M | 1 |
| Lichtensteiger, W | 1 |
6 other studies available for albuterol and Breast Neoplasms
| Article | Year |
|---|---|
The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models.
Topics: Adrenergic Agonists; Albuterol; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Prolife | 2023 |
The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.
Topics: Adrenergic Agonists; Albuterol; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Pro | 2017 |
New evidence in pulmonary and preventive medicine.
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Benzamides; Breast Neoplasms; Bronchodilator Ag | 2010 |
Involvement of α2- and β2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Albuterol; Animals; Antineoplastic Agents; Breast Neopl | 2012 |
Dyspnoea worsened by salmeterol.
Topics: Adenocarcinoma; Albuterol; Asthma; Breast Neoplasms; Bronchodilator Agents; Diagnosis, Differential; | 2002 |
Salbutamol exhibits androgenic activity in vitro.
Topics: Adrenergic beta-Agonists; Albuterol; Androgens; Breast Neoplasms; Cell Line, Tumor; Cell Proliferati | 2007 |